T&L Co Ltd
T&L Co Ltd provides medical equipment, supplies, and distribution services within the healthcare sector, generating revenue primarily through the sale and distribution of medical products.
Business. T&L Co Ltd (340570.KQ) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related supplies. It is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic presence are not disclosed in the available data.
Analyst recommendations
3 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
T&L Co Ltd (340570.KQ) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related supplies. It is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic presence are not disclosed in the available data.
T&L Co Ltd maintains a strong liquidity position, with a current ratio of 4.22 and cash and equivalents of KRW 9,178,746,320, indicating a solid ability to meet short-term obligations. The company's price-to-book ratio of 3.8 and price-to-tangible-book ratio of 3.8 suggest that the market values the company at a premium relative to its book value, reflecting investor confidence in its intangible assets and future earnings potential.
Profitability metrics show a return on equity (ROE) of 5.37% and a return on assets (ROA) of 4.63%, which are below the industry median for Medical Equipment, Supplies & Distribution. This suggests that the company is generating returns, but not at a rate that outperforms its peers. The operating margin, calculated as operating income of KRW 7,224,143,510 on revenue of KRW 24,813,644,590, is 29.11%, which is in line with the industry average.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to regional economic or regulatory risks.
Looking ahead, the company is projected to experience modest revenue growth, with a current FY outlook of 3.5% and a next FY outlook of 4.2%. These figures are in line with the industry's average growth expectations, suggesting a stable but not aggressive expansion strategy.
Risk factors for T&L Co Ltd include low liquidity risk and low dilution risk, as no immediate filing-based liquidity or dilution flags were detected. The company's debt-to-equity ratio is 0.0, indicating no long-term debt, which reduces financial leverage risk.
Recent events include the publication of the latest financial statements, which show a net income of KRW 7,099,391,140 and a free cash flow of KRW 6,146,585,870. Analysts have provided a mean price target of KRW 85,000, with a median of KRW 85,000, indicating a generally positive outlook from the investment community.
- T&L Co Ltd has a strong liquidity position with a current ratio of 4.22 and significant cash reserves.
- The company's ROE of 5.37% and ROA of 4.63% are below the industry median, indicating room for improvement in profitability.
- Revenue is concentrated in a single business segment, which may increase exposure to sector-specific risks.
- Analysts project a mean price target of KRW 85,000, suggesting a positive outlook despite the company's current valuation multiples.
- The company has no long-term debt, reducing financial leverage risk and improving its credit profile.
Bull / Bear case
Generated · model-assistedAnalysts project 49.1% upside to a mean price target of 85,000 KRW, reflecting strong buy consensus.
Revenue grew at a 22.9% CAGR over four years, demonstrating strong historical top-line expansion capabilities.
The company maintains a zero debt-to-equity ratio, providing a pristine balance sheet compared to the 0.2 cohort median.
Net income fell 18.0% year-over-year in FY2026, marking a sharp reversal from previous growth trends.
Cash conversion ratio of 0.08 sits in the bottom quartile of the cohort, suggesting poor earnings quality.
In focus — financials by report
Revenue KRW 33.40B, −28,2% YoY; Operating income −76,1% YoY.
- ▍Revenue KRW 33.40B, −28,2% YoY
- ▍Operating income −76,1% YoY
- ▍Net income −65,1% YoY
- ▍Free cash flow −99,7% YoY
- ▍Net margin 9.1%
Revenue KRW 40.67B, −16,5% YoY; Operating income −31,9% YoY.
- ▍Revenue KRW 40.67B, −16,5% YoY
- ▍Operating income −31,9% YoY
- ▍Net income −14,4% YoY
- ▍Free cash flow +11,4% YoY
- ▍Net margin 27.9%
Revenue KRW 38.76B, −29,3% YoY; Operating income −52,0% YoY.
- ▍Revenue KRW 38.76B, −29,3% YoY
- ▍Operating income −52,0% YoY
- ▍Net income −54,8% YoY
- ▍Free cash flow −133,8% YoY
- ▍Net margin 20.2%
Revenue KRW 51.32B, +106,8% YoY; Operating income +179,9% YoY.
- ▍Revenue KRW 51.32B, +106,8% YoY
- ▍Operating income +179,9% YoY
- ▍Net income +123,3% YoY
- ▍Free cash flow +139,4% YoY
- ▍Net margin 30.9%
Revenue KRW 46.52B; Operating income KRW 11.15B.
- ▍Revenue KRW 46.52B
- ▍Operating income KRW 11.15B
- ▍Net margin 18.8%
Revenue KRW 48.72B; Operating income KRW 17.83B.
- ▍Revenue KRW 48.72B
- ▍Operating income KRW 17.83B
- ▍Net margin 27.2%
Revenue KRW 54.84B; Operating income KRW 20.75B.
- ▍Revenue KRW 54.84B
- ▍Operating income KRW 20.75B
- ▍Net margin 31.6%
Revenue KRW 24.81B; Operating income KRW 7.22B.
- ▍Revenue KRW 24.81B
- ▍Operating income KRW 7.22B
- ▍Net margin 28.6%
Revenue KRW 164.16B, −6,1% YoY; Operating income −21,0% YoY.
- ▍Revenue KRW 164.16B, −6,1% YoY
- ▍Operating income −21,0% YoY
- ▍Net income −18,0% YoY
- ▍Free cash flow −36,8% YoY
- ▍Net margin 23.2%
Revenue KRW 174.89B, +51,5% YoY; Operating income +84,7% YoY.
- ▍Revenue KRW 174.89B, +51,5% YoY
- ▍Operating income +84,7% YoY
- ▍Net income +69,1% YoY
- ▍Free cash flow +151,1% YoY
- ▍Net margin 26.5%
Revenue KRW 115.46B, +41,5% YoY; Operating income +26,9% YoY.
- ▍Revenue KRW 115.46B, +41,5% YoY
- ▍Operating income +26,9% YoY
- ▍Net income +29,9% YoY
- ▍Free cash flow +195,2% YoY
- ▍Net margin 23.8%
Revenue KRW 81.58B, +13,5% YoY; Operating income +8,9% YoY.
- ▍Revenue KRW 81.58B, +13,5% YoY
- ▍Operating income +8,9% YoY
- ▍Net income +7,8% YoY
- ▍Free cash flow +9,0% YoY
- ▍Net margin 25.9%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 6 340,33 |
| Revenue | —no estimate | —no estimate | 213,5B KRW |
| Operating income | —no estimate | —no estimate | 62,5B KRW |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- T&L Co Ltd Market data — financials · 2026-05-26
- T&L Co Ltd Market data — analyst estimates · 2026-05-26